Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	283
Overall Study	STARTED	Selepressin 2.5 ng/kg/Min	197
Overall Study	STARTED	Selepressin 3.75 ng/kg/Min	189
Overall Study	STARTED	Selepressin 5.25 ng/kg/Min	199
Overall Study	Dosed	Placebo	266
Overall Study	Dosed	Selepressin 2.5 ng/kg/Min	191
Overall Study	Dosed	Selepressin 3.75 ng/kg/Min	177
Overall Study	Dosed	Selepressin 5.25 ng/kg/Min	194
Overall Study	COMPLETED	Placebo	265
Overall Study	COMPLETED	Selepressin 2.5 ng/kg/Min	184
Overall Study	COMPLETED	Selepressin 3.75 ng/kg/Min	174
Overall Study	COMPLETED	Selepressin 5.25 ng/kg/Min	189
Overall Study	NOT COMPLETED	Placebo	18
Overall Study	NOT COMPLETED	Selepressin 2.5 ng/kg/Min	13
Overall Study	NOT COMPLETED	Selepressin 3.75 ng/kg/Min	15
Overall Study	NOT COMPLETED	Selepressin 5.25 ng/kg/Min	10

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02508649/flow